July 2021 IMMUNOTHERAPY FOR BRAIN TUMORSFeaturing: Amy B. Heimberger, MD
Amy Heimberger, MD, an international leader in brain tumor research, is the scientific director of the Lou and Jean Malnati Brain Tumor Institute at the Robert H. Lurie Comprehensive Cancer Center, vice chair for Research in the Department of Neurosurgery and the Jean Malnati Miller Professor of Neurological Surgery at Northwestern Medicine. Dr. Heimberger’s research focuses on immune therapies for patients with central nervous system (CNS) malignancies. Here, she discusses her work. |
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|